TYR.F
Toyo Tire Corporation
FrankfurtEUREQUITY
Consumer Cyclical
DELAYED
Last price
20.20
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
20.20
Day high
20.20
Day low
20.20
Volume
10
Market cap
$3.11B
P/E (TTM)
9.67
52W range
19.10 – 26.40
Trailing performance
Returnvs SPY
1W
-1.94%
-0.6%
1M
-6.48%
-10.2%
3M
+1.00%
-2.1%
6M
-21.71%
-32.8%
YTD
-13.68%
-26.0%
1Y
-6.48%
-26.5%
3Y
+50.75%
-23.4%
5Y
+32.89%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on TYR.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
4.25M
Total on file
Fundamentals
Market cap$3.11B
Enterprise value$-48.14B
Revenue (TTM)$595.70B
Gross profit$230.74B
EBITDA$123.32B
Net income$59.72B
EPS (TTM)$2.09
Free cash flow$35.83B
Total cash$112.65B
Total debt$61.40B
Book value / share$19.05
Shares outstanding154.01M
Float149.83M
Short % of float—
Dividend yield3.82%
Beta (5Y)0.56
Valuation & profitability ratios
Trailing P/E9.67
Forward P/E—
PEG ratio—
Price / sales—
Price / book1.06
EV / revenue-0.08
EV / EBITDA-0.39
Gross margin38.73%
Operating margin11.02%
Profit margin10.03%
Return on equity11.62%
Return on assets7.34%
Debt / equity11.17
Current ratio2.80
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $594.92B | $565.36B | $552.83B | $497.21B | +5.2% |
| Operating revenue | $594.92B | $565.36B | $552.83B | $497.21B | +5.2% |
| Cost of revenue | $360.11B | $334.60B | $336.31B | $299.24B | +7.6% |
| Gross profit | $234.81B | $230.76B | $216.51B | $197.98B | +1.8% |
| Total operating expense | $137.46B | $136.78B | $139.61B | $153.93B | +0.5% |
| Operating income | $97.35B | $93.98B | $76.90B | $44.05B | +3.6% |
| Net interest income | $282.00M | -$602.00M | -$185.00M | -$755.00M | +146.8% |
| Pre-tax income | $89.24B | $101.58B | $96.08B | $66.62B | -12.2% |
| Tax provision | $25.63B | $26.77B | $23.90B | $18.67B | -4.3% |
| Net income | $63.61B | $74.81B | $72.27B | $47.96B | -15.0% |
| Net income to common | $63.61B | $74.81B | $72.27B | $47.96B | -15.0% |
| Basic EPS | 413.10 | 485.86 | 469.42 | 311.51 | -15.0% |
| Diluted EPS | 413.10 | 485.86 | 469.42 | 311.51 | -15.0% |
| EBIT | $90.25B | $103.08B | $97.15B | $67.90B | -12.4% |
| EBITDA | $125.80B | $138.18B | $127.92B | $94.65B | -9.0% |
| Basic shares | 153.99M | 153.98M | 153.96M | 153.95M | +0.0% |
| Diluted shares | 153.99M | 153.98M | 153.96M | 153.95M | +0.0% |
| Line item | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $86.64B | $52.88B | $41.60B | $55.62B | +63.8% |
| Cash & short-term investments | $86.64B | $52.88B | $41.60B | $55.62B | +63.8% |
| Accounts receivable | $130.37B | $107.79B | $109.47B | $83.29B | +20.9% |
| Inventory | $122.84B | $107.06B | $112.88B | $80.95B | +14.7% |
| Total current assets | $373.78B | $298.97B | $289.58B | $236.83B | +25.0% |
| Property, plant & equipment | $287.15B | $286.79B | $265.05B | $226.61B | +0.1% |
| Goodwill & intangibles | $22.12B | $15.80B | $8.53B | $6.33B | +40.0% |
| Total assets | $722.67B | $645.48B | $598.89B | $531.23B | +12.0% |
| Total current liabilities | $150.89B | $142.82B | $191.05B | $135.35B | +5.7% |
| Current debt | $20.45B | $11.65B | $67.78B | $40.20B | +75.5% |
| Long-term debt | $66.14B | $70.99B | $61.37B | $85.48B | -6.8% |
| Total debt | $102.05B | $97.87B | $129.15B | $125.67B | +4.3% |
| Total liabilities | $250.11B | $250.28B | $277.97B | $251.07B | -0.1% |
| Retained earnings | $275.99B | $221.33B | $159.84B | $125.12B | +24.7% |
| Shareholder equity | $472.55B | $395.20B | $320.68B | $279.95B | +19.6% |
| Working capital | $222.89B | $156.15B | $98.53B | $101.48B | +42.7% |
| Net tangible assets | $450.43B | $379.40B | $312.15B | $273.63B | +18.7% |
| Shares issued | 154.11M | 154.11M | 154.11M | 154.11M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $89.24B | $101.58B | $96.08B | $66.62B | -12.2% |
| Depreciation & amortisation | $35.55B | $35.11B | $30.77B | $26.75B | +1.3% |
| Change in working capital | -$14.81B | -$21.72B | $14.24B | -$30.02B | +31.8% |
| Operating cash flow | $93.06B | $67.06B | $86.50B | $15.17B | +38.8% |
| Capital expenditure | -$27.18B | -$27.84B | -$30.70B | -$46.39B | +2.4% |
| Investing cash flow | -$23.08B | -$15.21B | -$14.66B | -$16.71B | -51.7% |
| Dividends paid | -$19.99B | -$20.01B | -$10.77B | -$13.23B | +0.1% |
| Financing cash flow | -$43.83B | -$23.08B | -$62.89B | -$16.23B | -89.9% |
| Free cash flow | $65.88B | $39.22B | $55.80B | -$31.22B | +68.0% |
| End cash position | $116.80B | $86.33B | $52.80B | $41.60B | +35.3% |
| Line item | 2026-03-31 | 2025-03-31 | YoY |
|---|---|---|---|
| Basic EPS | 100.50 | 87.71 | +14.6% |
| Diluted EPS | 100.50 | 87.71 | +14.6% |
| Basic shares | 153.99M | 153.98M | +0.0% |
| Diluted shares | 153.99M | 153.98M | +0.0% |
| Line item | 2026-06-30 | 2025-06-30 | YoY |
|---|---|---|---|
| Cash & equivalents | $112.65B | $93.37B | +20.7% |
| Cash & short-term investments | $112.65B | $93.37B | +20.7% |
| Accounts receivable | $139.26B | $121.77B | +14.4% |
| Inventory | $138.30B | $126.52B | +9.3% |
| Total current assets | $418.22B | $373.27B | +12.0% |
| Property, plant & equipment | $285.66B | $273.26B | +4.5% |
| Goodwill & intangibles | $23.41B | $23.30B | +0.5% |
| Total assets | $768.19B | $707.04B | +8.6% |
| Total current liabilities | $149.18B | $139.79B | +6.7% |
| Current debt | $23.21B | $16.34B | +42.1% |
| Long-term debt | $38.18B | $60.38B | -36.8% |
| Total debt | $61.40B | $76.72B | -20.0% |
| Total liabilities | $218.34B | $229.18B | -4.7% |
| Retained earnings | $338.55B | $298.54B | +13.4% |
| Shareholder equity | $549.85B | $477.86B | +15.1% |
| Working capital | $269.04B | $233.48B | +15.2% |
| Net tangible assets | $526.44B | $454.56B | +15.8% |
| Shares issued | 154.11M | 154.11M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $159.54B | +5.1% |
| Next quarter | — | — | $168.01B | +5.3% |
| Current year | — | — | $621.64B | +103.5% |
| Next year | — | — | $659.99B | +6.2% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders2.76%
Held by institutions33.87%
Institutions holding148
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
20.32
-0.59% from price
SMA 20
21.30
-5.16% from price
SMA 50
21.05
-4.03% from price
SMA 100
20.66
-2.22% from price
SMA 200
21.89
-7.74% from price
EMA 12
20.57
-1.82% from price
EMA 26
20.92
-3.44% from price
EMA 50
20.95
-3.60% from price
RSI (14)
43.3
Neutral
MACD (12,26,9)
-0.35
Hist -0.17
ATR (14)
0.53
2.62% of price
Realised vol 30D
54.1%
Annualised
Bollinger upper
23.71
20, 2σ
Bollinger lower
18.89
20, 2σ
50 / 200 cross
Death
21.05 vs 21.89
Trend bias
Below 200
-7.74%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.42
Less volatile than market
Correlation to SPY
0.15
Largely independent
Realised vol 30D
54.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-27.7%
Peak to trough
Max drawdown 5Y
-36.5%
Peak to trough
ATR 14
0.53
2.62% of price
Beta (reported)
0.56
5Y monthly, from filing
Dividends & splits
Forward rate$0.77 / yr
Forward yield3.82%
5-year avg yield4.31%
Payout ratio33.52%
Ex-dividend dateDec 29, 2026
Next pay date—
Last split1:2
Split dateJun 26, 2014
Headlines
TME Pharma provides update on its activities
GlobeNewswire · 9m ago
American Chemical Society Names Syngenta's Camilla Corsi the 2026 Winner of Prestigious International Award for Research in Agrochemicals
Business Wire · 14m ago
Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and €40.25 Million PIPE Financing From New and Existing Investors
Business Wire · 14m ago
Board Update
GlobeNewswire · 14m ago
Aegon implements EUR 150 million increase in share buyback program
GlobeNewswire · 14m ago
TOMY's "TOMICA XROSS RESCUE" Diorama-based Short Animation Series to Begin Streaming Aug. 26, 2026
PR Newswire · 14m ago
Holding(s) in Company
GlobeNewswire · 14m ago
Summary of AB KN Energies webinar
GlobeNewswire · 14m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.